Clinical Care Options

?? Exciting Breast Cancer Education at SABCS 2024! ?? Join us live in San Antonio or tune in virtually for this free, CME-certified simulcast! Dive into the latest breast cancer breakthroughs, covering CDK4/6, ESR1 mutations, and SERDs, plus gain access to: ? Presentation slidesets ? On-demand webcasts ? Expert commentaries & clinical resources Learn from top experts to elevate your patient care! No SABCS registration required—choose how you’ll attend and don’t miss this unique opportunity. https://lnkd.in/edvRcXak

Access our expert-curated slideset on optimizing immunotherapy pathways to enhance patient outcomes in resectable #melanoma. Download it here: ?

Our DEA 8-hour training was designed with you specifically in mind. ?? Healthcare providers need the best methods and training for diagnosing, treating, and managing patients with opioid or substance use disorders. Improve the quality of care you provide ?? sign up here: https://bit.ly/3V8HA2J

In conjunction with the SUO annual meeting, join us for ‘Vital Questions for Treatment of Bladder Cancer: Expert Insights on Recent and Near-Future Changes’? ? Get expert insights from, Fed Ghali, MD and Tian Zhang MD, MHS,?on the latest clinical advances and guidelines in bladder cancer management.? ?? ?? Multidisciplinary approaches? ?? Key updates to enhance patient care? ?? & more!? ? Register:?https://lnkd.in/gPCzgPsZ?

Greg Mattingly, expert in digital therapeutics and psychiatry, answers a few questions about the practical aspects of incorporating digital therapeutics into practice. Read the article below ??

We’re just a little over a week away from our Hematology Satellite Symposia Preceding the 66th ASH Annual Meeting and Exposition. There is still time to register for in-person and virtual, but seats are filling quickly! ?? Join us: https://bit.ly/4gmrMC4

Join Virginia Kaklamani, MD, DSc for a live satellite symposium on Dec. 12. Dr. Kaklamani will cover estrogen receptor mutations in HR+ advanced breast cancer, including recommendations on mutation screening to guide therapeutic decision-making with selective estrogen receptor degraders (SERDs). Last chance to secure your spot: https://bit.ly/3BPiwH3

Plan your week ?? view our upcoming #CME event on the 26th and view our recently released #CME activities! Register for the event: https://bit.ly/4eGP3Ng Take our new activities ? ?? PROTAC ER Degraders in ER+/HER2- MBC Progressing After Endocrine Therapy – register: https://bit.ly/3V2QWg9 ? Interactive Tool to Guide Management of Anticoagulation in AF – register: https://bit.ly/4fW2uts

In this sneak preview from our latest premium course, The Emerging Role of AI in Healthcare, Brennan Spiegel, MD, MSHS paints a vivid picture of the future of what care could look like for healthcare professionals. This complete course is part of our Hot Topics in Healthcare series, covering the most highly requested topics from our members including AI, Clinician Health and Well-being, Medical Cannabis, and Obesity Management. ?? Use code HOT35 for 35% off the entire series today! Access it here: https://lnkd.in/gRJCF2zG ?

Patient Resource: Postsurgery Treatment Options for HER2-Negative Early-Stage Breast Cancer ??? ?? Download this guide to support shared decision-making on adjuvant therapy options for HER2-negative early-stage breast cancer patients. #BreastCancer #PatientCare?